![](https://webarchive.library.unt.edu/web/20090118165315im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Drug Development and Drug Interactions: Working Group Members
CDER
Office of Clinical Pharmacology and Biopharmaceutics
Sophia Abraham, PhD
Sayed Al-Habet, PhD
Raman Baweja, PhD
Gilbert Burckart, PhD**
Sang Chung, PhD
Philip Colangelo, PhD
Paul Hepp, PharmD |
Shiew-Mei Huang, PhD, FCP (Chair)
Ron Kavanagh, PhD
Lawrence J Lesko, PhD, FCP
Patrick Marroum, PhD
Srikanth Nallani, PhD
Wei Qiu, PhD |
Nam Atik Rahman, PhD
Kellie Reynolds, PharmD
Kenneth Thummel, PhD*
Xiaoxiong Wei, PhD
Sally Yasuda, PhD
Lei K Zhang, PhD
Jenny H Zheng, PhD |
* on sabbatical at FDA, July-August 2006
** on sabbatical at FDA, July - December 2006
Office of Medical Policy
Robert Temple, MD
Office of Pharmaceutical Sciences
Jerry Collins, PhD (now with NIH)
Soloman Sobel, MD
John Strong, PhD
David Frucht, PhD
Office of New Drug Evaluation
M David Green, PhD
CBER
Hon Sum Ko, MD
Toni Stifano
Back
to Top Back to Drug Interactions
PDF requires the free Adobe
Acrobat Reader
Date created: May 1, 2006
Date updated: October 11, 2006 |
![](https://webarchive.library.unt.edu/web/20090118165315im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |